The semaglutide Ozempic is well known the promote weight reduction, but it has been shown that some comorbidities that are tied in with type 2 diabetes are also improved when used. Consequently, cardiovascular disease can be fatal especially when compounded with the background effects of type 2 diabetes. This review of literature focuses on how cardiovascular disease improves in type 2 diabetic patients taking GLP-1 receptor agonists.

Cardiovascular Diseases (CVDs) were the leading causes of death from 1990 to 2015, with an estimated 17.9 million deaths worldwide. Psychosocial studies have uncovered associations between everyday aspects of life and physical health, especially relating to depression and stress. Research has shown that depression is a risk factor for CVDs, but the individual experiences that have a possibility of causing poor mental health were not explored, limiting these findings. This review will cover research on the impacts of socioeconomic status, debt, social dynamics, and ethnicity on cardiovascular health.